{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:48:05Z","timestamp":1791089285649,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.bone.2005.03.018","type":"journal-article","created":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T13:05:56Z","timestamp":1118322356000},"page":"148-158","source":"Crossref","is-referenced-by-count":552,"title":["SOST is a target gene for PTH in bone"],"prefix":"10.1016","volume":"37","author":[{"given":"Hansjoerg","family":"Keller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kneissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2005.03.018_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tem.2004.01.006","article-title":"Parathyroid hormone: a double-edged sword for bone metabolism","volume":"15","author":"Qin","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bone.2005.03.018_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(01)00798-3","article-title":"Parathyroid hormone-dependent signaling pathways regulating genes in bone cells","volume":"282","author":"Swarthout","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.bone.2005.03.018_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/er.20.3.345","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2005.03.018_bib4","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2005.03.018_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bone.2005.03.018_bib6","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1210\/en.140.8.3552","article-title":"Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation","volume":"140","author":"Lee","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.03.018_bib7","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/en.139.11.4743","article-title":"Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells","volume":"139","author":"Horwood","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.03.018_bib8","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2005.03.018_bib9","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/en.136.8.3632","article-title":"Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells","volume":"136","author":"Dobnig","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.03.018_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/8756-3282(94)90322-0","article-title":"Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow","volume":"15","author":"Nishida","year":"1994","journal-title":"Bone"},{"key":"10.1016\/j.bone.2005.03.018_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1359\/jbmr.1999.14.1.21","article-title":"Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I","volume":"14","author":"Kostenuik","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2005.03.018_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jbmr.5650110402","article-title":"Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats","volume":"11","author":"Meng","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2005.03.018_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/8756-3282(95)00332-2","article-title":"In vivo, human parathyroid hormone fragment (hPTH 1\u201334) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats","volume":"17","author":"Onyia","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.bone.2005.03.018_bib14","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1210\/en.136.11.5127","article-title":"Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats","volume":"136","author":"Schmidt","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.03.018_bib15","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1210\/en.136.8.3624","article-title":"Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1\u201334), and bovine PTH-(1\u201334)","volume":"136","author":"Leaffer","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.03.018_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2005.03.018_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S8756-3282(98)00129-X","article-title":"PTH(1\u201334) suppresses appositional bone formation by cultured rat cranial osteoblasts","volume":"23","author":"Gray","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.bone.2005.03.018_bib18","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/jbmr.5650111003","article-title":"Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages","volume":"11","author":"Isogai","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2005.03.018_bib19","doi-asserted-by":"crossref","first-page":"19374","DOI":"10.1074\/jbc.M108913200","article-title":"Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells","volume":"277","author":"Chen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2005.03.018_bib20","doi-asserted-by":"crossref","first-page":"19723","DOI":"10.1074\/jbc.M212226200","article-title":"Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics","volume":"278","author":"Qin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2005.03.018_bib21","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1210\/en.2002-220221","article-title":"Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos","volume":"143","author":"Demiralp","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.03.018_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/me.2002-0225","article-title":"Parathyroid hormone bone anabolic action requires Cbfa1\/Runx2-dependent signaling","volume":"17","author":"Krishnan","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bone.2005.03.018_bib23","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1359\/jbmr.2002.17.9.1570","article-title":"Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone","volume":"17","author":"Bikle","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2005.03.018_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s002239900715","article-title":"Immunohistochemical localization of selected early response genes expressed in trabecular bone of young rats given hPTH 1\u201334","volume":"65","author":"Liang","year":"1999","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2005.03.018_bib25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/(SICI)1097-4644(19980901)70:3<391::AID-JCB12>3.0.CO;2-O","article-title":"Intermittent administration of parathyroid hormone (1\u201334) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone","volume":"70","author":"McClelland","year":"1998","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bone.2005.03.018_bib26","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1210\/en.142.10.4349","article-title":"Evidence that anabolic effects of PTH on bone require IGF-I in growing mice","volume":"142","author":"Miyakoshi","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.03.018_bib27","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2005.03.018_bib28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"van Bezooijen","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bone.2005.03.018_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/me.2003-0227","article-title":"Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists","volume":"18","author":"Avsian-Kretchmer","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bone.2005.03.018_bib30","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1210\/jc.2003-030201","article-title":"Patients with Van Buchem disease, an osteosclerotic genetic disease, have elevated bone formation markers, higher bone density, and greater derived polar moment of inertia than normal","volume":"88","author":"Wergedal","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2005.03.018_bib31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2005.03.018_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(00)00448-8","article-title":"Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1\u201334)","volume":"28","author":"Kneissel","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2005.03.018_bib33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2005.03.018_bib34","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1210\/endo-125-3-1142","article-title":"Effects of interleukin-1 on bone turnover in normal mice","volume":"125","author":"Boyce","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.03.018_bib35","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/en.138.11.4607","article-title":"The effects of programmed administration of human parathyroid hormone fragment (1\u201334) on bone histomorphometry and serum chemistry in rats","volume":"138","author":"Dobnig","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.03.018_bib36","series-title":"Bone Research Protocols","first-page":"183","article-title":"Assessing bone formation using mouse calvarial organ cultures","author":"Garrett","year":"2003"},{"key":"10.1016\/j.bone.2005.03.018_bib37","series-title":"Bone Research Protocols","first-page":"169","article-title":"Analysis of osteoclast function in mouse calvarial cultures","author":"Marshall","year":"2003"},{"key":"10.1016\/j.bone.2005.03.018_bib38","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1210\/endo-123-5-2597","article-title":"A new highly potent parathyroid hormone antagonist: [d-Trp12, Tyr34]bPTH-(7\u201334)NH2","volume":"123","author":"Goldman","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.03.018_bib39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jbmr.5650110402","article-title":"Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats","volume":"11","author":"Meng","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2005.03.018_bib40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/382448a0","article-title":"Increased bone formation in osteocalcin-deficient mice","volume":"382","author":"Ducy","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bone.2005.03.018_bib41","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1359\/jbmr.1997.12.12.2089","article-title":"Temporal changes of mRNA expression of matrix proteins and parathyroid hormone and parathyroid hormone-related protein (PTH\/PTHrP) receptor in bone development","volume":"12","author":"Kondo","year":"1997","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.bone.2005.03.018_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/er.23.3.279","article-title":"Sex steroids and the construction and conservation of the adult skeleton","volume":"23","author":"Riggs","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2005.03.018_bib43","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1359\/jbmr.2001.16.8.1399","article-title":"Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats","volume":"16","author":"Wronski","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2005.03.018_bib44","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1359\/jbmr.2001.16.3.448","article-title":"Parathyroid hormone\/parathyroid hormone-related peptide type 1 receptor in human bone","volume":"16","author":"Langub","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2005.03.018_bib45","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0092-8674(00)80260-3","article-title":"Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia","volume":"89","author":"Mundlos","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bone.2005.03.018_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1399-0004.2003.00036.x","article-title":"The natural history of sclerosteosis","volume":"63","author":"Hamersma","year":"2003","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bone.2005.03.018_bib47","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2005.03.018_bib48","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bone.2004.04.019","article-title":"Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts","volume":"35","author":"Sutherland","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2005.03.018_bib49","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1210\/en.137.11.4592","article-title":"Establishment and hormonal regulation of a conditionally transformed preosteocytic cell line from adult human bone","volume":"137","author":"Bodine","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2005.03.018_bib50","first-page":"1105","article-title":"Cycloheximide induces the alpha 1B adrenergic receptor gene by activation of transcription in DDT1 MF-2 smooth muscle cells","volume":"44","author":"Hu","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bone.2005.03.018_bib51","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1359\/jbmr.1997.12.3.384","article-title":"An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats","volume":"12","author":"Armamento-Villareal","year":"1997","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.bone.2005.03.018_bib52","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/jbmr.5650090807","article-title":"Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase","volume":"9","author":"Rixon","year":"1994","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328205001171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328205001171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T11:36:18Z","timestamp":1550921778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328205001171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S8756328205001171"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2005.03.018","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}